World Stem Cell Summit
  • About WSCS
    • About Us
    • Past Speakers
    • Annual Regenerative Medicine Essentials Course
    • 2023 Public Day
    • Symposium Intersection of RegMed & Healthspan
    • Effective Patient Advocacy
    • Regenerative Medicine & the Commercial Space Economy
    • Hot Topics in 2023 at World Stem Cell Summit
  • Partners/Sponsors
    • Partners/Sponsors
    • Sponsorship Opportunities
  • Upcoming Events
  • News & Media
    • News and Opinions
    • WSCS 2023 Photos
    • WSCS Video
  • Contact Us
Select Page
Moderna sues Pfizer, BioNTech over COVID-19 vaccine

Moderna sues Pfizer, BioNTech over COVID-19 vaccine

by admin | Sep 12, 2022 | News and Opinions

Moderna is suing Pfizer and BioNTech, alleging they copied technology that Moderna first developed years before the pandemic in producing the first COVID-19 vaccine approved in the U.S., the company announced Friday. Driving the news: Moderna is seeking unspecified...
‘Synthetic’ embryo with brain and beating heart grown from stem cells by Cambridge scientists

‘Synthetic’ embryo with brain and beating heart grown from stem cells by Cambridge scientists

by admin | Sep 11, 2022 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions

By Sarah Collins and Jacqueline Garget – University of Cambridge Researchers from the University of Cambridge have created model embryos from mouse stem cells that form a brain, a beating heart, and the foundations of all the other organs of the body – a new...
Hydrogel that outperforms cartilage could be in human knees in 2023

Hydrogel that outperforms cartilage could be in human knees in 2023

by admin | Sep 11, 2022 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions

By Michael Irving – New Atlas Joint pain is a common ailment of aging, thanks to cartilage’s tendency to wear out. Now, researchers at Duke University have developed a new hydrogel that’s stronger and more durable than the real thing, which could make for longer...
Personalized Immunotherapy Shows Promise Beyond Cancer

Personalized Immunotherapy Shows Promise Beyond Cancer

by admin | Sep 10, 2022 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions

AUDIO -Science Friday Article   CAR T cell therapy, a type of immunotherapy in which a patient’s own immune cells are modified to create a hybrid immune cell that destroys cancer cells, was first developed over a decade ago. Now, researchers are continuing to...
The New York Stem Cell Foundation Mourns the Loss of CEO Susan L. Solomon

The New York Stem Cell Foundation Mourns the Loss of CEO Susan L. Solomon

by admin | Sep 9, 2022 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions

One of the great patient advocates of our time, Susan Solomon, has passed away. Susan was a visionary leader and true force of nature. A diabetes mom, she launched the New York Stem Cell Foundation that has supported cutting edge research and constructed a major...
Large number of stem cell lines carry significant DNA damage, say researchers

Large number of stem cell lines carry significant DNA damage, say researchers

by admin | Sep 9, 2022 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions

DNA damage caused by factors such as ultraviolet radiation affect nearly three-quarters of all stem cell lines derived from human skin cells, say Cambridge researchers, who argue that whole genome sequencing is essential for confirming if cell lines are usable. Stem...
Page 143 of 209« First«...102030...141142143144145...150160170...»Last »

Recent Posts

  • CRISPR grapefruit without the bitterness are now in development
  • Alzheimer’s scrambles memories while the brain rests
  • New 3D brain organoids reveal how glioblastoma evades treatment
  • Toward Engineering a Human Kidney Collecting-Duct System
  • Podcast – SENESCENT CELLS – An Important Target for Diseases of Aging
  • Q&A: The Future of Space Medicine Research
World Stem Cell Summit Logo - White version
Copyright © 2026 Regenerative Medicine Foundation, All rights reserved.
  • Follow
  • Follow
  • Follow
  • Follow
  • Follow